ASX Filings

Opthea To Present at SVB Leerink Global Healthcare Conference

February 10, 2022

Additional Formats

PDF Version

Change in substantial holding

February 9, 2022

Opthea Announces Presentation at the Angiogenesis, Exudation, and Degeneration 2022 Conference

February 9, 2022

Additional Formats

PDF Version

Change in substantial holding

February 7, 2022

Change in substantial holding

February 4, 2022

Change in substantial holding

February 3, 2022

Form F-3 Registration Statement

February 2, 2022

Opthea Announces Establishment of At-The-Market Equity Program

February 1, 2022

Becoming a substantial holder

January 31, 2022

Ceasing to be a substantial holder

January 28, 2022